🔎 Trials Near Me

Pradžia › Nutukimas › Arizona › Phoenix

Nutukimas klinikiniai tyrimai Phoenix, AZ

22 tyrimai dėl Nutukimas ieško dalyvių vietose Phoenix ir aplinkui (apytiksliai 30 mylių spinduliu). Atidarykite tyrimą, kad pamatytumėte, kas gali dalyvauti ir kaip susisiekti su tyrimo komanda.

Oficialus tyrimo tekstas (anglų kalba)

Ieškote dalyvių tyrimui? Pateikite jį šio puslapio viršuje – $99 už 30 dienų →

Early Tracking of Childhood Health Determinants (ETCHED) Study

Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
  • NIDDK, Phoenix, Phoenix
1 Day – 99 Years · Visoms lytims · Atnaujinta 2026-09-28 · NCT03481829

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

Renkami dalyviai3 fazė
  • RIO Clinical Trials - Phoenix, Phoenix
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-22 · NCT07392190

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Renkami dalyviai3 fazė
  • Research Site, Phoenix
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-22 · NCT07784270

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Renkami dalyviai3 fazė
  • Synexus Clinical Research US, Inc., Phoenix
  • Medical Advancement Centers of Arizona, Phoenix
Amžius nuo 45 iki 99 · Visoms lytims · Atnaujinta 2026-09-22 · NCT07037433

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

Renkami dalyviai3 fazė
  • Elite Clinical Studies, LLC, Phoenix
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-22 · NCT07353931

Variability In Mixed Meal Tests: Fixed Versus Adjusted to Energy Needs Caloric Dose

Renkami dalyviaiLaukiami sveiki savanoriai
  • NIDDK, Phoenix, Phoenix
Amžius nuo 18 iki 99 · Visoms lytims · Atnaujinta 2026-09-21 · NCT06223555

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

Renkami dalyviai3 fazė
  • AURORA-1 Clinical Site, Phoenix
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-16 · NCT07743463

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Renkami dalyviai3 fazė
  • AURORA-2 Clinical Site, Phoenix
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-16 · NCT07743450

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

Renkami dalyviai3 fazė
  • HonorHealth, Phoenix
  • Medical Advancement Centers of Arizona, Phoenix
Amžius nuo 18 iki 99 · Visoms lytims · Atnaujinta 2026-09-16 · NCT07037459

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

Renkami dalyviai2 fazė
  • Helios Clinical Research - Phoenix, Phoenix
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-09-14 · NCT06897475

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

Renkami dalyviai3 fazėLaukiami sveiki savanoriai
  • ACCOMPLISH-2 Research Site, Phoenix
Amžius nuo 18 iki 79 · Visoms lytims · Atnaujinta 2026-09-11 · NCT07654374

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

Renkami dalyviai2 fazė
  • Synexus Clinical Research US, Inc., Phoenix
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-09-08 · NCT07215559

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

Renkami dalyviai3 fazė
  • Kailera Clinical Site, Phoenix
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-03 · NCT07284901

Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes

Renkami dalyviai3 fazė
  • Kailera Clinical Site, Phoenix
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-01 · NCT07284979

The Effects of Increasing Caloric Intake on Diet-Induced Thermogenesis and 24h Energy Expenditure

Renkami dalyviaiLaukiami sveiki savanoriai
  • NIDDK, Phoenix, Phoenix
Amžius nuo 18 iki 60 · Visoms lytims · Atnaujinta 2026-08-28 · NCT05545306

Redefining Evaluation of Adiposity and Leanness: Broadening Objective Diagnostics for Obesity

Renkami dalyviaiStebimasis tyrimas
  • Exponent Phoenix, Phoenix
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-20 · NCT07776678

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

Renkami dalyviai3 fazė
  • Honor Health, Phoenix
  • Arizona Research Center, Phoenix
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-18 · NCT07567001

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

Renkami dalyviai3 fazė
  • ACCOMPLISH-1 Research Site, Phoenix
Amžius nuo 18 iki 79 · Visoms lytims · Atnaujinta 2026-08-10 · NCT07654361

Fibrosis Lessens After Metabolic Surgery

Renkami dalyviai4 fazėLaukiami sveiki savanoriai
  • Banner Health Center, Phoenix
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-07-31 · NCT06374875

A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

Renkami dalyviai3 fazė
  • Arizona Research Center, Inc., Phoenix
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-09 · NCT07481630

Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation

Renkami dalyviai3 fazė
  • The University of Arizona College of Medicine- Phoenix, Phoenix
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2025-11-14 · NCT06499857

Nutukimas tyrimai kituose miestuose

Kiti tyrimai Phoenix

Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.